Skip to content

MindMaze Therapeutics Invites to 2026 Annual General Meeting

MindMaze Therapeutics Holding SA has announced its 2026 Annual General Meeting scheduled for June 25, 2026, in Geneva, Switzerland. The agenda includes the re-election of current Board members, election of Brad Hollinger and Zach Henderson to the Board, approval of the 2025 Annual Report, and various votes regarding the company’s governance and compensation matters. MindMaze is recognized for its innovations in neurotherapeutics aimed at improving patient recovery.

GENEVA, June 3, 2026 /PRNewswire/ — MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today published the invitation to its 2026 Annual General Meeting (AGM), which will be held on June 25, 2026,…